15-17 June 2017.
Walking with McArdle's course,
2-9 August 2017.
AGSD-UK Annual Conference,
28-29 October 2017.
Also known as Pompe disease or acid maltase deficiency.
We apologise that the Pompe Pages are not available at this time as they have recently been seriously compromised and have been removed.
In time we will migrate the Pompe pages into this AGSD-UK web site.
Specialist Care Advisor
The AGSD-UK employs Jane Lewthwaite as a specialist care advisor for Pompe patients and families. Please use the contact form to email her directly about any issues relating to Pompe disease and she will reply to you by email or phone.
Please help AGSD-UK to campaign for improvements in the procedures for adding new conditions to the UK Screening programme.
Newborn screening is the only way to reliably detect Pompe disease at an early age. Infants, in particular, need to receive therapy within days or weeks of birth in order to protect them from irreversible muscle damage, heart failure and premature death.
AGSD-UK is a member of the UK Patient Advocates for Newborn Screening, PANS, and as a result of their discussions a paper has been written to seek support from the UK Governments and Members of Parliament.
The paper can be downloaded through this link. It, or the link, can be incorporated into a letter to your MP.
Your MP can be contacted by email using the government Search Facility.
If you need any help with any of this then please contact Allan Muir, Charity Director, using the contact form.
Association for Glycogen Storage Disease (UK) LimitedRegistered Charity No 1132271